 PARSIPPANY, NJ, Nov. 19, 2020 GLOBE NEWSWIRE -- Interpace Biosciences, Inc. Interpace or the Company NASDAQ: IDXG on November 18, 2020 received notice from the Listing Qualifications Staff the Staff of The Nasdaq Stock Market LLC Nasdaq indicating that, due to the delay in the filing of the Companys Form 10-Q for the quarterly period ended September 30, 2020 the Form 10-Q with the Securities and Exchange Commission the SEC, Interpace does not currently satisfy Nasdaq Listing Rule 5250c1, which requires the timely filing of all periodic reports with the SEC. The deficiency has no immediate effect on the listing or trading of the Companys common stock on Nasdaq. 